Washington — US president-elect Donald Trump’s choice to run the Department of Health and Human Services may have broken the law by making a stock purchase just before he introduced legislation that would have benefited the firm, the Senate’s leading Democrat charged on Tuesday. A confirmation hearing for Tom Price, a Republican congressman and orthopaedic surgeon from Georgia, was scheduled for Wednesday before the Senate health committee. If confirmed, he would be a key player in carrying out Trump’s plans to overhaul Democratic President Barack Obama’s signature healthcare law. CNN reported on Sunday that Price bought between $1,001 and $15,000 worth of shares last March in Zimmer Biomet Holdings, a medical device manufacturer. Days later, he introduced legislation in the House of Representatives that would have delayed a regulation that could have ultimately damaged the company, CNN said. Senator Chuck Schumer of New York, the leader of the Democratic minority in the Senate, cal...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.